1683.6000 -35.10 (-2.04%)
NSE May 23, 2025 15:56 PM
Volume: 8.3M
High volume today

Phillip Capital
SUNP received final approval from US FDA for gGleevec with 180days marketing exclusivity in the US and is set to launch it on February 1, 2016 (as per its settlement agreementwithNovartis).WehadearliermodeledgGleevecopportunityconsideringthe...
Sun Pharmaceutical I.. has an average target of 2054.00 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended